{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:49:20Z","timestamp":1784040560829,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12185-024-03725-z","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T08:03:22Z","timestamp":1709193802000},"page":"442-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictive factors for l-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-1162","authenticated-orcid":false,"given":"Chane","family":"Choed-Amphai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-0923","authenticated-orcid":false,"given":"Jiraporn","family":"Khorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-259X","authenticated-orcid":false,"given":"Lalita","family":"Sathitsamitphong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-3443","authenticated-orcid":false,"given":"Rungrote","family":"Natesirinilkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9123-9177","authenticated-orcid":false,"given":"Pimlak","family":"Charoenkwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"issue":"2","key":"3725_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","volume":"112","author":"AM Linabery","year":"2008","unstructured":"Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992\u20132004). Cancer. 2008;112(2):416\u201332.","journal-title":"Cancer"},{"issue":"9","key":"3725_CR2","first-page":"2215","volume":"12","author":"S Wiangnon","year":"2011","unstructured":"Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, et al. Childhood cancer incidence and survival 2003\u20132005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12(9):2215\u201320.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"16","key":"3725_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541\u201352.","journal-title":"N Engl J Med"},{"issue":"11","key":"3725_CR4","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.7314\/APJCP.2015.16.11.4609","volume":"16","author":"P Seksarn","year":"2015","unstructured":"Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of childhood acute lymphoblastic leukemia treated using the Thai national protocols. Asian Pac J Cancer Prev. 2015;16(11):4609\u201314.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"17","key":"3725_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1200\/JCO.19.03024","volume":"38","author":"S Gupta","year":"2020","unstructured":"Gupta S, Wang C, Raetz EA, Schore R, Salzer WL, Larsen EC, et al. Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2020;38(17):1897\u2013905.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3725_CR6","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"K Schmiegelow","year":"2016","unstructured":"Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen TL, Halsey C, et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol. 2016;17(6):e231\u20139.","journal-title":"Lancet Oncol"},{"issue":"16","key":"3725_CR7","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2217\/fon.14.138","volume":"10","author":"MJ Burke","year":"2014","unstructured":"Burke MJ. How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia. Future Oncol. 2014;10(16):2615\u201327.","journal-title":"Future Oncol"},{"issue":"4","key":"3725_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1365-2141.2001.03009.x","volume":"114","author":"HJ Muller","year":"2001","unstructured":"Muller HJ, Beier R, Loning L, Blutters-Sawatzki R, Dorffel W, Maass E, et al. Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. Br J Haematol. 2001;114(4):794\u20139.","journal-title":"Br J Haematol"},{"issue":"2","key":"3725_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/cncr.25489","volume":"117","author":"R Pieters","year":"2011","unstructured":"Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A, et al. l-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer. 2011;117(2):238\u201349.","journal-title":"Cancer"},{"issue":"7","key":"3725_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/MPH.0b013e3181e6f003","volume":"32","author":"EA Raetz","year":"2010","unstructured":"Raetz EA, Salzer WL. Tolerability and efficacy of l-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010;32(7):554\u201363.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"3725_CR11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1200\/JCO.2000.18.7.1525","volume":"18","author":"MH Woo","year":"2000","unstructured":"Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK, et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2000;18(7):1525\u201332.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3725_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3324\/haematol.2015.137380","volume":"101","author":"IM van der Sluis","year":"2016","unstructured":"van der Sluis IM, Vrooman LM, Pieters R, Baruchel A, Escherich G, Goulden N, et al. Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica. 2016;101(3):279\u201385.","journal-title":"Haematologica"},{"issue":"4","key":"3725_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/10428194.2015.1101098","volume":"57","author":"N Hijiya","year":"2016","unstructured":"Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57(4):748\u201357.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"3725_CR14","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/MPH.0b013e3181e003c7","volume":"32","author":"S Akbayram","year":"2010","unstructured":"Akbayram S, Dogan M, Akgun C, Caksen H, Oner AF. A desensitization protocol in children with l-asparaginase hypersensitivity. J Pediatr Hematol Oncol. 2010;32(5):e187\u201391.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"3725_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28021","volume":"67","author":"KJ August","year":"2020","unstructured":"August KJ, Farooki S, Fulbright JM, August A, Portnoy JM, Pommert L, et al. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatr Blood Cancer. 2020;67(1): e28021.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"3725_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/08880018.2019.1634778","volume":"36","author":"A Verma","year":"2019","unstructured":"Verma A, Chen K, Bender C, Gorney N, Leonard W, Barnette P. PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability. Pediatr Hematol Oncol. 2019;36(5):277\u201386.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"3725_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.htct.2019.10.007","volume":"43","author":"AP Battistel","year":"2021","unstructured":"Battistel AP, Rocha BSD, Santos MTD, Daudt LE, Michalowski MB. Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia. Hematol Transfus Cell Ther. 2021;43(1):9\u201314.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"3725_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/clpt.2010.94","volume":"88","author":"SH Chen","year":"2010","unstructured":"Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, et al. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther. 2010;88(2):191\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3725_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40272-015-0129-1","volume":"17","author":"LS Abbott","year":"2015","unstructured":"Abbott LS, Zakova M, Shaikh F, Shewaramani N, Punnett A, Dupuis LL. Allergic reactions associated with intravenous versus intramuscular pegaspargase: a retrospective chart review. Paediatr Drugs. 2015;17(4):315\u201321.","journal-title":"Paediatr Drugs"},{"issue":"4","key":"3725_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bjhh.2017.08.002","volume":"39","author":"ACD Santos","year":"2017","unstructured":"Santos ACD, Land MGP, Silva NPD, Santos KO, Lima-Dellamora EDC. Reactions related to asparaginase infusion in a 10-year retrospective cohort. Rev Bras Hematol Hemoter. 2017;39(4):337\u201342.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"3725_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.htct.2019.01.013","volume":"42","author":"CV Medawar","year":"2020","unstructured":"Medawar CV, Mosegui GBG, Vianna CMM, Costa T. PEG-asparaginase and native Escherichia coli l-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review. Hematol Transfus Cell Ther. 2020;42(1):54\u201361.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"1","key":"3725_CR22","first-page":"9","volume":"1","author":"M Nesbit","year":"1979","unstructured":"Nesbit M, Chard R, Evans A, Karon M, Hammond GD. Evaluation of intramuscular versus intravenous administration of l-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol. 1979;1(1):9\u201313.","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"1","key":"3725_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/pbc.26200","volume":"64","author":"H Hasan","year":"2017","unstructured":"Hasan H, Shaikh OM, Rassekh SR, Howard AF, Goddard K. Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: a meta-analysis and systematic review. Pediatr Blood Cancer. 2017;64(1):81\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"3725_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27797","volume":"66","author":"SL Cooper","year":"2019","unstructured":"Cooper SL, Young DJ, Bowen CJ, Arwood NM, Poggi SG, Brown PA. Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutions. Pediatr Blood Cancer. 2019;66(8): e27797.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"3725_CR25","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.3109\/10428194.2011.596963","volume":"52","author":"W Stock","year":"2011","unstructured":"Stock W, Douer D, DeAngelo DJ, Arellano M, Advani A, Damon L, et al. Prevention and management of asparaginase\/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk Lymphoma. 2011;52(12):2237\u201353.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3725_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pbc.22225","volume":"54","author":"LM Vrooman","year":"2010","unstructured":"Vrooman LM, Supko JG, Neuberg DS, Asselin BL, Athale UH, Clavell L, et al. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;54(2):199\u2013205.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"3725_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/mpo.10096","volume":"38","author":"BK Albertsen","year":"2002","unstructured":"Albertsen BK, Schroder H, Jakobsen P, Avramis VI, Muller HJ, Schmiegelow K, et al. Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase. Med Pediatr Oncol. 2002;38(5):310\u20136.","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"3725_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/10428190701292049","volume":"48","author":"B Zalewska-Szewczyk","year":"2007","unstructured":"Zalewska-Szewczyk B, Andrzejewski W, Mlynarski W, Jedrychowska-Danska K, Witas H, Bodalski J. The anti-asparagines antibodies correlate with l-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2007;48(5):931\u20136.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03725-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03725-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03725-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T13:15:07Z","timestamp":1711199707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03725-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3725"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03725-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the Institutional Research Board\/Ethics Committee (IRB\/EC) of Chiang Mai University, Chiang Mai, Thailand.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and analyzed for this study are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}